APA Zitierstil

Watanabe, S., Tanaka, J., Ota, T., Kondo, R., Tanaka, H., Kagamu, H., . . . Yoshizawa, H. (2011). Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: A retrospective analysis. BioMed Central.

Chicago Zitierstil

Watanabe, Satoshi, et al. Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited From Prior Effective Gefitinib Therapy: A Retrospective Analysis. BioMed Central, 2011.

MLA Zitierstil

Watanabe, Satoshi, et al. Clinical Responses to EGFR-tyrosine Kinase Inhibitor Retreatment in Non-small Cell Lung Cancer Patients Who Benefited From Prior Effective Gefitinib Therapy: A Retrospective Analysis. BioMed Central, 2011.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.